Home > Specialists > Vascular Surgery > Dr. Jie Yin (尹杰)
Specialty & Clinical Focus:
Vascular surgery specialist at Peking University First Hospital in Beijing, with a clinical focus on interventional vascular surgery, CHIVA procedures for varicose veins, complex vascular malformations, venous disease, hemodialysis access, and diabetic foot care.
Professional Title & Qualifications:
Associate Chief Physician,
Ph.D. in Surgery
Hospital & Department：
Peking University First Hospital – Department of Interventional Vascular Surgery
(address: No. 8 Xishiku Street, Xicheng District, Beijing, 100034)
Dr. Jie Yin (尹杰) - Vascular Surgery Specialist
Personal Biography
Dr. Jie Yin is an Associate Chief Physician in the Department of Interventional Vascular Surgery at Peking University First Hospital in Beijing. He received his Ph.D. in Surgery from Peking University Health Science Center and is among the early clinicians in China to perform CHIVA procedures for varicose veins. His clinical work combines interventional, endovascular and open surgical techniques for vascular conditions including varicose veins, complex vascular malformations, venous disease, hemodialysis access and diabetic foot care. Dr. Yin emphasizes ultrasound-guided precision, preservation of vascular function and long-term limb function when clinically appropriate.
Why Choose Dr. Jie Yin?
International patients considering vascular care in Beijing may value Dr. Jie Yin’s focused experience in interventional vascular surgery, especially for varicose veins, vascular malformations, venous disease, hemodialysis access and diabetic foot-related vascular problems. His reported surgical volume includes over 20,000 vascular procedures and more than 5,000 ultrasound-guided CHIVA procedures, giving patients a clear basis for requesting a remote specialist-review pathway before making travel decisions.
Dr. Yin’s “preserve rather than excise” philosophy is particularly relevant for patients who need careful planning around vessel function, limb preservation and minimally invasive options. A well-prepared remote review package can help the specialist office understand medical history, imaging, ultrasound findings and prior treatments before any in-person pathway in China is considered.
Pre-Travel Case Review & Specialist Liaison
Considering medical travel to Beijing for vascular care? MedBridgeNZ can help prepare your case for a remote specialist-review or appointment-triage pathway with Dr. Jie Yin’s office where available, before you commit to flights or major travel arrangements.
Our team coordinates medical-record organization, imaging and ultrasound-report preparation, translation support, client-authorized document transfer and appointment communication. This process can help clarify administrative and travel feasibility before any in-person pathway at Peking University First Hospital is pursued.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jie Yin
Areas of Expertise
Varicose Veins (CHIVA Surgery): Utilizing ultrasound-guided precise positioning and hemodynamic correction through minimal incisions. This approach treats the condition while preserving the great saphenous vein and may allow patients to walk normally soon after surgery, depending on individual circumstances.
Complex Vascular Malformations: Comprehensive treatment of conditions like Klippel-Trenaunay (KT) syndrome, using an individualized combination of interventional embolization, radiofrequency ablation, and surgery to support symptom improvement and protect limb appearance.
Venous Diseases: Diagnosis and treatment of deep vein thrombosis and primary lower extremity deep venous valve insufficiency.
Hemodialysis Access: Establishment and maintenance of "lifelines" for uremia patients, including complex arteriovenous fistula surgery, artificial blood vessel transplantation, and interventional maintenance to resolve strictures or thrombosis.
Diabetic Foot: Comprehensive endovascular treatment utilizing lower extremity arterial balloon dilatation and stent implantation to open occluded vessels and provide critical blood flow for limb salvage.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.9/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
16,100 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
August 2016 – Present: Associate Chief Physician, Department of Interventional Vascular Surgery, Peking University First Hospital.
July 2010 – July 2016: Assistant Researcher and Attending Physician, Department of Interventional Vascular Surgery, Peking University First Hospital.
Education & Training
Ph.D. in Surgery, Peking University Health Science Center.
Awards & Honors
Eight-time recipient of the Haodf Annual Good Doctor Award (2015, 2017, 2018, 2019, 2020, 2023, 2024, 2025).
Academic & Professional Memberships
Member of the 5th Committee of the Vascular Surgery Branch, Beijing Medical Association, and Deputy Leader of the Lower Extremity Artery Group.
Member of the Hemodialysis Access Group, Vascular Surgery Branch of the Chinese Medical Doctor Association.
Standing Committee Member of the Tumor Vascular Committee, Peripheral Vascular Surgery Society of the Chinese Microcirculation Society.
Director of the Vascular Surgery Branch, Beijing Medical Doctor Association.
Research & Publications
Associate Editor of "Analysis of Difficult Cases in Chinese Micro-case Competition".
Co-author of critical medical texts including "Analysis of Difficult Cases in Vascular Surgery," "Geriatric Cardiology," and "Aortology".
Pioneered domestic hemodialysis access establishment, performing the first chest wall artificial blood vessel graft for dialysis access in China.
First in China to report the innovative implantation of totally implantable venous access ports (TIVAP) via external jugular vein cutdown for oncology patients, reducing surgical risks.
Selected Peer-Reviewed Publications
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Yin the right specialist for my specific vascular condition?
Dr. Yin’s visible clinical focus includes minimally invasive vascular surgery, CHIVA procedures for varicose veins, complex vascular malformations, venous disease, hemodialysis access and diabetic foot-related vascular care. For overseas patients, MedBridgeNZ can coordinate records preparation, translation support and client-authorized document transfer so the relevant specialist office may review materials for appointment triage or preliminary case-screening where available. This does not replace an in-person clinical assessment or licensed specialist advice, but it can help you organize the information needed before considering medical travel to Beijing.
How can an international patient request appointment coordination with Dr. Yin in Beijing?
International patients can contact MedBridgeNZ to request appointment communication support with Peking University First Hospital where available. Our team helps organize medical records, prior imaging, ultrasound reports and question lists, and coordinates translation and administrative communication with the relevant third-party office. We can also support medical invitation or visa-document coordination, travel planning and non-clinical bilingual administrative support for hospital visits in Beijing.
What happens after a remote specialist-review pathway if I decide to travel to China?
If the specialist office indicates that an in-person pathway may be appropriate and the patient chooses to proceed, MedBridgeNZ can coordinate the next administrative steps, including appointment request follow-up, itinerary planning, accommodation logistics and non-clinical bilingual support. Hospital admission, diagnostic testing, treatment planning and surgery decisions remain subject to the hospital’s normal procedures and the licensed specialist’s clinical judgment.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients considering vascular specialist-care pathways in China. We help with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.